Clinical Trial Update: Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma [NA]

View source ↗

Summary

This entry notes completion of a clinical trial evaluating lymphodepletion followed by adoptive cell transfer with high-dose interleukin-2 in patients with meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Melanoma | NA | Status: COMPLETED | Results posted: 2014-06-02